132 related articles for article (PubMed ID: 38301954)
1. Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays.
Inniss NL; Rzhetskaya M; Ling-Hu T; Lorenzo-Redondo R; Bachta KE; Satchell KJF; Hultquist JF
SLAS Discov; 2024 Apr; 29(3):100145. PubMed ID: 38301954
[TBL] [Abstract][Full Text] [Related]
2. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
[TBL] [Abstract][Full Text] [Related]
3. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity.
Yue K; Yao B; Shi Y; Yang Y; Qian Z; Ci Y; Shi L
Biochem Biophys Res Commun; 2022 Apr; 601():129-136. PubMed ID: 35245742
[TBL] [Abstract][Full Text] [Related]
4. In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity.
Mohammad TSH; Gupta Y; Reidl CT; Nicolaescu V; Gula H; Durvasula R; Kempaiah P; Becker DP
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982188
[TBL] [Abstract][Full Text] [Related]
5. A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase nsP13 in the unwinding of duplex RNA.
Jang KJ; Jeong S; Kang DY; Sp N; Yang YM; Kim DE
Sci Rep; 2020 Mar; 10(1):4481. PubMed ID: 32161317
[TBL] [Abstract][Full Text] [Related]
6. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors.
Yazdi AK; Pakarian P; Perveen S; Hajian T; Santhakumar V; Bolotokova A; Li F; Vedadi M
ACS Infect Dis; 2022 Aug; 8(8):1533-1542. PubMed ID: 35822715
[TBL] [Abstract][Full Text] [Related]
7. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
Freidel MR; Armen RS
PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
[TBL] [Abstract][Full Text] [Related]
8. A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance.
Grimes SL; Choi YJ; Banerjee A; Small G; Anderson-Daniels J; Gribble J; Pruijssers AJ; Agostini ML; Abu-Shmais A; Lu X; Darst SA; Campbell E; Denison MR
mBio; 2023 Aug; 14(4):e0106023. PubMed ID: 37338298
[TBL] [Abstract][Full Text] [Related]
9. The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association.
Zheng T; Shen B; Bai Y; Li E; Zhang X; Hu Y; Gao T; Dong Q; Zhu L; Jin R; Shi H; Liu H; Gao Y; Liu X; Cao C
J Virol; 2024 Apr; 98(4):e0156523. PubMed ID: 38445884
[TBL] [Abstract][Full Text] [Related]
10. Biochemical analysis of SARS-CoV-2 Nsp13 helicase implicated in COVID-19 and factors that regulate its catalytic functions.
Sommers JA; Loftus LN; Jones MP; Lee RA; Haren CE; Dumm AJ; Brosh RM
J Biol Chem; 2023 Mar; 299(3):102980. PubMed ID: 36739951
[TBL] [Abstract][Full Text] [Related]
11. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
Zeng J; Weissmann F; Bertolin AP; Posse V; Canal B; Ulferts R; Wu M; Harvey R; Hussain S; Milligan JC; Roustan C; Borg A; McCoy L; Drury LS; Kjaer S; McCauley J; Howell M; Beale R; Diffley JFX
Biochem J; 2021 Jul; 478(13):2405-2423. PubMed ID: 34198322
[TBL] [Abstract][Full Text] [Related]
12. Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase.
Zhang C; Yu J; Deng M; Zhang Q; Jin F; Chen L; Li Y; He B
Molecules; 2024 May; 29(10):. PubMed ID: 38792162
[TBL] [Abstract][Full Text] [Related]
13. The Coronavirus helicase in replication.
Grimes SL; Denison MR
Virus Res; 2024 Aug; 346():199401. PubMed ID: 38796132
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Inhibitors of the SARS-CoV-2 NSP13 Helicase via Structure-Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations.
Di Paco G; Macchiagodena M; Procacci P
ChemMedChem; 2024 May; 19(10):e202400095. PubMed ID: 38456332
[TBL] [Abstract][Full Text] [Related]
15. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.
Shu T; Huang M; Wu D; Ren Y; Zhang X; Han Y; Mu J; Wang R; Qiu Y; Zhang DY; Zhou X
Virol Sin; 2020 Jun; 35(3):321-329. PubMed ID: 32500504
[TBL] [Abstract][Full Text] [Related]
16. Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase.
Mickolajczyk KJ; Shelton PMM; Grasso M; Cao X; Warrington SE; Aher A; Liu S; Kapoor TM
Biophys J; 2021 Mar; 120(6):1020-1030. PubMed ID: 33340543
[TBL] [Abstract][Full Text] [Related]
17. Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication.
Corona A; Madia VN; De Santis R; Manelfi C; Emmolo R; Ialongo D; Patacchini E; Messore A; Amatore D; Faggioni G; Artico M; Iaconis D; Talarico C; Di Santo R; Lista F; Costi R; Tramontano E
Antiviral Res; 2023 Sep; 217():105697. PubMed ID: 37562607
[TBL] [Abstract][Full Text] [Related]
18. Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach.
Romeo I; Ambrosio FA; Costa G; Corona A; Alkhatib M; Salpini R; Lemme S; Vergni D; Svicher V; Santoro MM; Tramontano E; Ceccherini-Silberstein F; Artese A; Alcaro S
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364347
[TBL] [Abstract][Full Text] [Related]
19. Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
Habtemariam S; Nabavi SF; Banach M; Berindan-Neagoe I; Sarkar K; Sil PC; Nabavi SM
Arch Med Res; 2020 Oct; 51(7):733-735. PubMed ID: 32536457
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
Li A; Zhang B; Zhao K; Yin Z; Teng Y; Zhang L; Xu Z; Liang K; Cheng X; Xia Y
J Virol; 2023 Jul; 97(7):e0051223. PubMed ID: 37347173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
